Vanguard Group’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $44.5M | Sell |
1,038,408
-4,715
| -0.5% | -$178K | ﹤0.01% | 2219 |
|
|
2025
Q3 | $29.6M | Sell |
1,043,123
-9,748
| -0.9% | -$292K | ﹤0.01% | 2430 |
|
|
2025
Q2 | $19.7M | Buy |
1,052,871
+24,799
| +2% | +$470K | ﹤0.01% | 2567 |
|
|
2025
Q1 | $18.5M | Buy |
1,028,072
+15,141
| +1% | +$307K | ﹤0.01% | 2541 |
|
|
2024
Q4 | $17M | Buy |
1,012,931
+27,640
| +3% | +$530K | ﹤0.01% | 2661 |
|
|
2024
Q3 | $15.9M | Buy |
985,291
+23,662
| +2% | +$278K | ﹤0.01% | 2712 |
|
|
2024
Q2 | $7.9M | Buy |
961,629
+24,887
| +3% | +$260K | ﹤0.01% | 3042 |
|
|
2024
Q1 | $13.9M | Buy |
936,742
+41,420
| +5% | +$558K | ﹤0.01% | 2782 |
|
|
2023
Q4 | $13M | Buy |
895,322
+8,547
| +1% | +$87.4K | ﹤0.01% | 2803 |
|
|
2023
Q3 | $9.58M | Sell |
886,775
-206,908
| -19% | -$2.49M | ﹤0.01% | 2913 |
|
|
2023
Q2 | $14.1M | Sell |
1,093,683
-42,230
| -4% | -$571K | ﹤0.01% | 2760 |
|
|
2023
Q1 | $15M | Sell |
1,135,913
-72,467
| -6% | -$1.15M | ﹤0.01% | 2738 |
|
|
2022
Q4 | $18.1M | Buy |
1,208,380
+14,160
| +1% | +$130K | ﹤0.01% | 2667 |
|
|
2022
Q3 | $14.1M | Buy |
1,194,220
+146,303
| +14% | +$1.98M | ﹤0.01% | 2787 |
|
|
2022
Q2 | $11.8M | Buy |
1,047,917
+134,696
| +15% | +$2.71M | ﹤0.01% | 2900 |
|
|
2022
Q1 | $27.3M | Buy |
913,221
+10,410
| +1% | +$282K | ﹤0.01% | 2607 |
|
|
2021
Q4 | $23.9M | Sell |
902,811
-5,514
| -0.6% | -$166K | ﹤0.01% | 2745 |
|
|
2021
Q3 | $33M | Buy |
908,325
+714
| +0.1% | +$28.1K | ﹤0.01% | 2593 |
|
|
2021
Q2 | $39.4M | Buy |
907,611
+12,102
| +1% | +$457K | ﹤0.01% | 2492 |
|
|
2021
Q1 | $30.6M | Sell |
895,509
-19,051
| -2% | -$754K | ﹤0.01% | 2583 |
|
|
2020
Q4 | $32M | Buy |
914,560
+24,422
| +3% | +$707K | ﹤0.01% | 2413 |
|
|
2020
Q3 | $21.4M | Sell |
890,138
-11,418
| -1% | -$280K | ﹤0.01% | 2425 |
|
|
2020
Q2 | $16.5M | Buy |
901,556
+19,021
| +2% | +$342K | ﹤0.01% | 2517 |
|
|
2020
Q1 | $13.8M | Sell |
882,535
-989
| -0.1% | -$21.1K | ﹤0.01% | 2465 |
|
|
2019
Q4 | $18.9M | Buy |
883,524
+49,820
| +6% | +$1.03M | ﹤0.01% | 2560 |
|
|
2019
Q3 | $15.6M | Buy |
833,704
+115,979
| +16% | +$2.4M | ﹤0.01% | 2594 |
|
|
2019
Q2 | $18.7M | Buy |
717,725
+94,723
| +15% | +$2.14M | ﹤0.01% | 2536 |
|
|
2019
Q1 | $16M | Buy |
623,002
+160,147
| +35% | +$3.66M | ﹤0.01% | 2603 |
|
|
2018
Q4 | $10.6M | Sell |
462,855
-278,641
| -38% | -$7.86M | ﹤0.01% | 2746 |
|
|
2018
Q3 | $23.8M | Buy |
741,496
+4,678
| +0.6% | +$140K | ﹤0.01% | 2502 |
|
|
2018
Q2 | $20.9M | Buy |
736,818
+82,859
| +13% | +$2.95M | ﹤0.01% | 2546 |
|
|
2018
Q1 | $23.1M | Buy |
653,959
+32,066
| +5% | +$1.28M | ﹤0.01% | 2442 |
|
|
2017
Q4 | $24.1M | Buy |
621,893
+60,690
| +11% | +$2.31M | ﹤0.01% | 2421 |
|
|
2017
Q3 | $14.3M | Sell |
561,203
-42,776
| -7% | -$1.04M | ﹤0.01% | 2644 |
|
|
2017
Q2 | $16.5M | Buy |
603,979
+34,875
| +6% | +$955K | ﹤0.01% | 2542 |
|
|
2017
Q1 | $18.8M | Buy |
569,104
+96,035
| +20% | +$2.45M | ﹤0.01% | 2467 |
|
|
2016
Q4 | $11.3M | Sell |
473,069
-12,685
| -3% | -$363K | ﹤0.01% | 2695 |
|
|
2016
Q3 | $17.8M | Buy |
485,754
+23,529
| +5% | +$675K | ﹤0.01% | 2414 |
|
|
2016
Q2 | $10.3M | Buy |
462,225
+11,919
| +3% | +$296K | ﹤0.01% | 2635 |
|
|
2016
Q1 | $9.37M | Buy |
450,306
+108,296
| +32% | +$2.67M | ﹤0.01% | 2646 |
|
|
2015
Q4 | $10.4M | Buy |
342,010
+15,427
| +5% | +$468K | ﹤0.01% | 2618 |
|
|
2015
Q3 | $8.07M | Buy |
326,583
+9,912
| +3% | +$296K | ﹤0.01% | 2718 |
|
|
2015
Q2 | $10.2M | Buy |
316,671
+8,979
| +3% | +$343K | ﹤0.01% | 2664 |
|
|
2015
Q1 | $11M | Buy |
307,692
+8,237
| +3% | +$226K | ﹤0.01% | 2600 |
|
|
2014
Q4 | $6.8M | Sell |
299,455
-73,124
| -20% | -$1.48M | ﹤0.01% | 2733 |
|
|
2014
Q3 | $7.23M | Sell |
372,579
-39,149
| -10% | -$1.11M | ﹤0.01% | 2648 |
|
|
2014
Q2 | $14.9M | Buy |
411,728
+410
| +0.1% | +$13.9K | ﹤0.01% | 2333 |
|
|
2014
Q1 | $16M | Buy |
411,318
+34,124
| +9% | +$1.22M | ﹤0.01% | 2274 |
|
|
2013
Q4 | $10.8M | Sell |
377,194
-102,292
| -21% | -$3M | ﹤0.01% | 2429 |
|
|
2013
Q3 | $17.2M | Buy |
479,486
+23,711
| +5% | +$865K | ﹤0.01% | 2171 |
|
|
2013
Q2 | $15.2M | Buy |
+455,775
| New | +$20.7M | ﹤0.01% | 2154 |
|
Other funds holding RIGL
AC
Vanguard Group's RIGL Position: Q4 2025 in Review
Vanguard Group reduced its Rigel Pharmaceuticals (RIGL) stake by 0.45% in Q4 2025, selling an estimated $178K and leaving 1,038,408 shares worth $44.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2219.
Vanguard Group first reported a position in RIGL in Q2 2013 and has held it in 51 quarters since. 193 funds tracked by Wall St. Rank hold RIGL as of Q4 2025.
- Vanguard Group held 1,038,408 shares of Rigel Pharmaceuticals worth $44.5M as of Q4 2025.
- Vanguard Group sold 4,715 Rigel Pharmaceuticals shares in Q4 2025, an estimated $178K.
- Rigel Pharmaceuticals made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #2219 holding.
- Vanguard Group first reported a position in Rigel Pharmaceuticals in Q2 2013 and has held it in 51 quarters since.
- 193 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q4 2025.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.